MedPath

The effect of melatonin on the lipid levels

Phase 2
Conditions
Menopause.
Symptoms such as flushing, sleeplessness, headache, lack of concentration, associated with menopause
Registration Number
IRCT2012090810774N1
Lead Sponsor
Vice chancellery of research,Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
240
Inclusion Criteria

The inclusion criteria of the study: having general health based on the Goldberg’s questionnaire (achieving score less than 23); married women between 40 to 60 years old; not using vitamin supplements; not having used hormone therapy during the last 3 months; complete physical health in physical examinations; cessation of the menstrual cycle for at least 6 months; and FSH above 40 IU. The exclusion criteria of the study: A history of active liver, kidney, heart, thyroid, diabetes and inflammatory diseases; inability to continue drug use for any reason; unwillingness to continue participation in the study; and showing allergic reaction to the drug. In addition, if any of the conditions listed in the inclusion criteria were violated at any time, the volunteer would be excluded from the study.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum lipid. Timepoint: Before intervention,3 month after intervention. Method of measurement: Lipid of plasma were measured based on the international units.
Secondary Outcome Measures
NameTimeMethod
Changes in body mass index. Timepoint: Before intervention,3 month after intervention. Method of measurement: Dividing weight in kilograms by the square of height in meters.
© Copyright 2025. All Rights Reserved by MedPath